Search
for
Sort by
Research 301–330 of 1000+
- Dermatology of androgen-related disorders
- Idiopathic Hirsutism*
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Testosterone Therapy in Premenopausal Women
- Recent therapeutic developments for acne
- Farmácia Aliança - Maia
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- Analysis of androgen receptor expression and activity in the mouse brain
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Hirsutism: Diagnosis and management
- Polycystic ovary syndrome: A review for dermatologists
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Hirsutism: diagnosis and treatment
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Hypothalamic DNA methylation in rats with dihydrotestosterone‐induced polycystic ovary syndrome: effects of low‐frequency electro‐acupuncture
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Endocrine disorders and hormonal therapy for adolescent acne
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Case 33-2015
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Plant-based approaches in the management of polycystic ovary syndrome: A review
- Understanding Polycystic Ovary Syndrome
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional